Vaxcyte (NASDAQ: PCVX) net income
Vaxcyte reported a net loss of $766.6m for fiscal 2025; in fiscal 2024 it reported a net loss of $463.9m. Earnings per share were −$5.63.
Vaxcyte's best year of the last 7 was fiscal 2019. It reported a loss in 7 of those 7 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$766.6m | — | — | −$5.63 |
| 2024 | −$463.9m | — | — | −$3.80 |
| 2023 | −$402.3m | — | — | −$4.14 |
| 2022 | −$223.5m | — | — | −$3.44 |
| 2021 | −$100.1m | — | — | −$1.93 |
| 2020 | −$89.2m | — | — | −$3.02 |
| 2019 | −$50.3m | — | — | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Vaxcyte net income compared with its sector
By net income for its latest fiscal year, Vaxcyte ranks 487th of the 501 US health care companies with a page on Celsmar.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 485th | BridgeBio Pharma | −$732.9m | −146.0% |
| 486th | Biohaven | −$738.8m | — |
| 487th | Vaxcyte | −$766.6m | — |
| 488th | Cytokinetics | −$785.0m | −891.6% |
| 489th | Teleflex | −$905.6m | −45.4% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Vaxcyte
- How much did Vaxcyte earn in fiscal 2025?
- Vaxcyte reported a net loss of $766.6m for fiscal 2025. In fiscal 2024 it reported a net loss of $463.9m.
- What are the earnings per share of Vaxcyte?
- They were −$5.63 in fiscal 2025, compared with −$3.80 in fiscal 2024.
- Where does Vaxcyte rank in its sector by net income?
- It ranks 487th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Vaxcyte come from?
- From the annual report (Form 10-K) that Vaxcyte files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Vaxcyte files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019. More on Vaxcyte: the Vaxcyte page · annual accounts · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.